Company / Return on Assets (ROA)
Glaukos Corp. Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-21.0%
FY2025
5-year range
-21.0% / -4.7%
FY2021-FY2025
Trend
-39.9%
vs FY2024
Sector context
#145 of 158
Health Care
What the data says
Among 158 Health Care companies, Glaukos Corp. is in the bottom 8% for return on assets (roa). Return on Assets (ROA) has declined for 4 consecutive years, from -4.7% in FY2021 to -21.0% in FY2025.
Based on SEC 10-K filings.
-21.0% in FY2025 with a 5-year CAGR of -9.0%.
Declined from -14.3% to -21.0% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -11.1pp
- 5-Year Change
- -9.0pp
- 10-Year Change
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 158This company -21.0% Sector average -2.2%
▼
-858.2% below sector average
Key checks
Key Insights
- Glaukos Corp.'s return on assets (roa) has declined for 4 consecutive years.
- In FY2025, return on assets (roa) decreased 39.9% year-over-year.
- Currently 18.8pp below the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -21.0% | -39.9% |
| FY2024 | -15.0% | -4.9% |
| FY2023 | -14.3% | -44.6% |
| FY2022 | -9.9% | -109.7% |
| FY2021 | -4.7% | +60.6% |
| FY2020 | -12.0% | -736.7% |
| FY2019 | 1.9% | +130.0% |
| FY2018 | -6.3% | -10333.3% |
| FY2017 | -0.1% | -101.8% |
| FY2016 | 3.4% | +110.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026